Indonesian Regulator BPOM Nears Agreement with China on Drug and Food Safety
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
What happened
The Indonesian Food and Drug Authority (BPOM) is pushing to renew its agreement with the National Medical Products Administration (NMPA), China's counterpart to BPOM. The draft of the renewed Memorandum of Understanding (MoU) is complete and is expected to be signed soon. The MoU seeks to cover various regulations, including medicines, vaccines, biological products, pharmaceutical ingredients, cosmetics, and digital regulatory technology.
From antaranews.com
Why it matters
The renewed MoU aims to establish a broader framework for international trade and regulatory cooperation between Indonesia and China. BPOM's existing status as a WHO-Listed Authority (WLA) demonstrates strong manufacturing capabilities. The agreement could pave the way for Chinese investment in Indonesian vaccine technology.
From antaranews.com
Who's involved
- IndonesiaGeopolitical state whose regulatory body is the subject of the agreement.
- Indonesian Food and Drug AuthorityIndonesian government agency responsible for product regulation and international trade.
- BeijingLocation where the parties are currently meeting to finalize the agreement.
Keep exploring
The entities involved
-
Indonesia
island country in Southeast Asia and Oceania
-
Indonesian Food and Drug Authority
Indonesian government agency
Nothing else this week.
Related events
- Indonesia is deepening economic ties with Mozambique, noting exports of palm oil and soap.
- CPTPP accession talks are underway for Indonesia and the UAE, alongside broader dialogues with the WTO, EU, and ASEAN.
- Rapide Group proposes acquiring an Indonesian coffee business as the global coffee market is tracked.
- The administration is directing the state to focus on foreign trade.